Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Journal of Clinical Psychopharmacology
|
November 3, 2016
Hypersalivation as an Adverse Drug Reaction Related to Lithium Carbonate: A Case Report
Rami Bou Khalil, Lama Souaiby, Roba Ghossan, et al.
Journal of Radiology Case Reports
|
December 15, 2022
Diffuse Idiopathic Skeletal Hyperostosis and Ankylosing Spondylitis: A Challenging Case and Review of the Literature
Roba Ghossan, Soha Haddad Zebouni, Tonine Younan Farah, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases
|
December 20, 2023
Cardiovascular Safety of Febuxostat in Patients With Gout or Hyperuricemia: A Systematic Review of Randomized Controlled Trials
Roba Ghossan, Ouidade Aitisha Tabesh, Fouad Fayad, et al.
RMD Open
|
February 8, 2023
Sustained complete B cell depletion is associated with rituximab efficacy in connective tissue disorders-associated interstitial lung disease
Omar Al Tabaa, Roba Ghossan, Alice Combier, et al.
Research in Veterinary Science
|
July 31, 2016
Development of renal atrophy in murine 2 kidney 1 clip hypertension is strain independent
Sonu Kashyap, Rajendra Boyilla, Paula J Zaia, et al.
Rheumatology (Oxford, England)
|
October 4, 2023
Should complete B cell depletion be maintained in patients treated long-term with rituximab for rheumatoid arthritis?
Roba Ghossan, Omar Al Tabaa, Alice Combier, et al.
RMD Open
|
May 19, 2022
Very low rate of humoral response after a third COVID-19 vaccine dose in patients with autoimmune diseases treated with rituximab and non-responders to two doses
Samuel Bitoun, Jérôme Avouac, Julien Henry, et al.
Rheumatology (Oxford, England)
|
March 31, 2022
Increased antibody response after SARS-CoV-2 mRNA-based vaccination in rituximab-treated patients with previous COVID-19 infection
Jérôme Avouac, Roba Ghossan, Omar Al Tabaa, et al.
Rheumatology (Oxford, England)
|
April 9, 2026
18F-fluorodeoxyglucose PET/CT uptake characteristics in ICI-induced polymyalgia rheumatica compared to idiopathic polymyalgia rheumatica
Arthur Bouchut, Thibaut Jacquet, Yasmine Gouyette, et al.
Joint Bone Spine
|
April 7, 2024
Recommendations of the French Society of Rheumatology for the management in current practice of patients with polymyalgia rheumatica
Daniel Wendling, Omar Al Tabaa, Baptiste Chevet, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Journal of Clinical Psychopharmacology
|
November 3, 2016
Hypersalivation as an Adverse Drug Reaction Related to Lithium Carbonate: A Case Report
Rami Bou Khalil, Lama Souaiby, Roba Ghossan, et al.
Journal of Radiology Case Reports
|
December 15, 2022
Diffuse Idiopathic Skeletal Hyperostosis and Ankylosing Spondylitis: A Challenging Case and Review of the Literature
Roba Ghossan, Soha Haddad Zebouni, Tonine Younan Farah, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases
|
December 20, 2023
Cardiovascular Safety of Febuxostat in Patients With Gout or Hyperuricemia: A Systematic Review of Randomized Controlled Trials
Roba Ghossan, Ouidade Aitisha Tabesh, Fouad Fayad, et al.
RMD Open
|
February 8, 2023
Sustained complete B cell depletion is associated with rituximab efficacy in connective tissue disorders-associated interstitial lung disease
Omar Al Tabaa, Roba Ghossan, Alice Combier, et al.
Research in Veterinary Science
|
July 31, 2016
Development of renal atrophy in murine 2 kidney 1 clip hypertension is strain independent
Sonu Kashyap, Rajendra Boyilla, Paula J Zaia, et al.
Rheumatology (Oxford, England)
|
October 4, 2023
Should complete B cell depletion be maintained in patients treated long-term with rituximab for rheumatoid arthritis?
Roba Ghossan, Omar Al Tabaa, Alice Combier, et al.
RMD Open
|
May 19, 2022
Very low rate of humoral response after a third COVID-19 vaccine dose in patients with autoimmune diseases treated with rituximab and non-responders to two doses
Samuel Bitoun, Jérôme Avouac, Julien Henry, et al.
Rheumatology (Oxford, England)
|
March 31, 2022
Increased antibody response after SARS-CoV-2 mRNA-based vaccination in rituximab-treated patients with previous COVID-19 infection
Jérôme Avouac, Roba Ghossan, Omar Al Tabaa, et al.
Rheumatology (Oxford, England)
|
April 9, 2026
18F-fluorodeoxyglucose PET/CT uptake characteristics in ICI-induced polymyalgia rheumatica compared to idiopathic polymyalgia rheumatica
Arthur Bouchut, Thibaut Jacquet, Yasmine Gouyette, et al.
Joint Bone Spine
|
April 7, 2024
Recommendations of the French Society of Rheumatology for the management in current practice of patients with polymyalgia rheumatica
Daniel Wendling, Omar Al Tabaa, Baptiste Chevet, et al.
Page
of 2